Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/53296
Title: Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium.
Authors: Nagle C.M.;Ibiebele T.I.;Na R.;Bandera E.V.;Cramer D.;Doherty J.A.;Giles G.G.;Goodman M.T.;Hanley G.E.;Harris H.R.;Jensen A.;Kjaer S.K.;Lee A. ;McGuire V.;Milne R.L.;Qin B.;Richardson J.;Sasamoto N.;Schildkraut J.M.;Sieh W.;Terry K.L.;Titus L.;Trabert B.;Wentzensen N.;Wu A.H.;Berchuck A.;Pike M.C.;Pearce C.L.;Webb P.M.
Monash Health Department(s): Monash University - School of Clinical Sciences at Monash Health
Institution: (Nagle, Ibiebele, Na) Gynaecological Cancers Group, Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
(Bandera, Qin) Cancer Prevention and Control Program, Rutgers Cancer Institute, New Brunswick, NJ, USA
(Cramer, Terry) Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, 9 Boston, MA, USA
(Doherty) Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, United States
(Giles, Milne) Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
(Goodman) Cancer Prevention and Control Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
(Hanley) University of British Columbia, Department of Obstetrics & Gynaecology, Vancouver, Canada
(Harris) Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA
(Jensen) Department of Virus, Lifestyle and Genes, Copenhagen, Denmark
(Kjaer) Department of Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
(Lee) Department of Public Health, California State University, Fullerton, CA, United States
(McGuire) Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, United States
(Richardson) Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Patient advocate
(Sasamoto) Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
(Schildkraut) Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States
(Sieh) Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, United States
(Titus) Dartmouth Cancer Center, NH, United States
(Trabert) Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; Department of Obstetrics and Gynecology, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA
(Wentzensen) Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States
(Wu) Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
(Berchuck) Division of Gynecologic Oncology, Duke University School of Medicine, Durham, NC, United States
(Pike) Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
(Pearce) Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States
(Webb) Gynaecological Cancers Group, Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; University of Queensland, School of Public Health, Brisbane, Queensland, Australia
Issue Date: 26-Feb-2025
Copyright year: 2025
Place of publication: United States
Publication information: The American Journal of Clinical Nutrition. (no pagination), 2025. Date of Publication: 05 Feb 2025.
Journal: The American Journal of Clinical Nutrition
Abstract: BACKGROUND: Prognosis following a diagnosis of invasive epithelial ovarian cancer is poor. Some studies have suggested modifiable behaviors, like diet, are associated with survival but the evidence is inconsistent. OBJECTIVE(S): To pool data from studies conducted around the world to evaluate the relation between dietary indices, foods, and nutrients from food sources and survival after a diagnosis of ovarian cancer. METHOD(S): This analysis from the Multidisciplinary Ovarian Cancer Outcomes Group within the Ovarian Cancer Association Consortium included 13 studies with 7,700 individuals with ovarian cancer, who completed food-frequency questionnaires regarding their pre-diagnosis diet. Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for associations with overall survival were estimated using Cox proportional hazards models. RESULT(S): Overall, there was no association between any of the seven dietary indices (representing pre-diagnosis diet) evaluated and survival; however, associations differed by tumor stage. While there were no consistent associations among those with advanced disease, among those with earlier stage (local/regional) disease, higher scores on the alternate Healthy Eating Index (aHR Quartile 4 versus 1 = 0.66, 95% CI=0.50, 0.87), Healthy Eating Index-2015 (aHR 0.75; 95% CI=0.59, 0.97) and alternate Mediterranean diet (aHR 0.76; 95% CI=0.60, 0.98) were associated with better survival. Better survival was also observed for individuals with early-stage disease who reported higher intakes of dietary components that contribute to the healthy diet indices (aHR for Q4 versus Q1: vegetables 0.71; 95% CI=0.56, 0.91), tomatoes (aHR 0.72; 95% CI=0.57, 0.91) and nuts and seeds (aHR 0.71; 95% CI=0.55, 0.92). In contrast, there were suggestions of worse survival with higher scores on two of the three inflammatory indices and higher intake of trans-fatty acids. CONCLUSION(S): Adherence to a more heathy, less inflammatory diet may confer a survival benefit for individuals with early-stage ovarian cancer.Copyright © 2025. Published by Elsevier Inc.
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.ajcnut.2025.02.004
PubMed URL: 39921094
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/53296
Type: Article In Press
Subjects: ovary cancer
Type of Clinical Study or Trial: Observational study (cohort, case-control, cross sectional, or survey)
Qualitative study
Appears in Collections:Articles

Show full item record

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.